Disease oriented treatment of metastatic colorectal cancer (CRC) with dose-dense 5-FU/Folinic acid (FU/FA) combination chemotherapy

被引:0
|
作者
Loeffler, TM [1 ]
Droege, C [1 ]
Lenfers, BHM [1 ]
Hausamen, TU [1 ]
机构
[1] Stadt Kliniken Dortmund, Dept Med, Dortmund, Germany
关键词
D O I
10.1016/S0959-8049(99)80661-3
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
228
引用
收藏
页码:S73 / S73
页数:1
相关论文
共 50 条
  • [21] CHEMOTHERAPY OF ADVANCED COLORECTAL-CARCINOMA WITH FOLINIC ACID 5-FLUOROURACIL (FA FU)
    SCHALHORN, A
    LERNER, J
    POSSINGER, K
    WILMANNS, W
    BLUT, 1988, 57 (04): : 245 - 245
  • [22] DOSE INTENSITY AND TOLERANCE IMPROVEMENT OF CETUXIMAB, IRINOTECAN, 5-FU AND FOLINIC ACID IN PATIENTS WITH METASTATIC CRC; A PHARMACOKINETIC AND PHARMACOGENETIC APPROACH
    Gamelin, E.
    Metges, J.
    Adenis, A.
    Raoul, J.
    Lam, Y.
    Lecomte, T.
    Faroux, R.
    Luet, D.
    Masliah, C.
    Berger, V.
    ANNALS OF ONCOLOGY, 2008, 19 : 131 - 131
  • [23] High efficacy of sequential chemotherapy (CT) with dose-dense modified TCF regimen (TCF-DD) followed by CT with oxaliplatin, folinic acid (FA), 5-fluorouracil (5-FU) and irinotecan (COFFI) in metastatic gastric cancer (MGC)
    Dalla Chiesa, M.
    Tomasello, G.
    Buti, S.
    Negri, F.
    Brighenti, M.
    Lazzarelli, S.
    Auzzani, A.
    Curti, A.
    Martinotti, M.
    Passalacqua, R.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [24] Randomized trial of either UFT or infusional 5-FU in combination with Erbitux, oxaliplatin and folinic acid in first-line treatment of metastatic colorectal cancer
    Rolski, J.
    Barone, C.
    Schaberl-Moser, R.
    Eggleton, S.
    Douillard, J.
    ANNALS OF ONCOLOGY, 2008, 19 : 27 - 28
  • [25] REGIONAL 5-FU AND FOLINIC ACID FOR MULTIPLE COLORECTAL LIVER METASTASES
    WARREN, HW
    ANDERSON, JH
    KERR, D
    COOKE, TG
    MCARDLE, CS
    GASTROENTEROLOGY, 1993, 104 (04) : A461 - A461
  • [26] Twelve weeks of protracted venous infusion of fluorouracil (5-FU) is as effective as 6 months of bolus 5-FU and folinic acid as adjuvant treatment in colorectal cancer
    Saini, A
    Norman, AR
    Cunningham, D
    Chau, I
    Hill, M
    Tait, D
    Hickish, T
    Iveson, T
    Lofts, F
    Jodrell, D
    Ross, PJ
    Oates, J
    BRITISH JOURNAL OF CANCER, 2003, 88 (12) : 1859 - 1865
  • [27] Twelve weeks of protracted venous infusion of fluorouracil (5-FU) is as effective as 6 months of bolus 5-FU and folinic acid as adjuvant treatment in colorectal cancer
    A Saini
    A R Norman
    D Cunningham
    I Chau
    M Hill
    D Tait
    T Hickish
    T Iveson
    F Lofts
    D Jodrell
    P J Ross
    J Oates
    British Journal of Cancer, 2003, 88 : 1859 - 1865
  • [28] Oxaliplatin/5-FU chemotherapy without leucovorin in metastatic colorectal cancer.
    Shim, BY
    Cho, HJ
    Yang, JM
    Kim, HJ
    Kim, JK
    Kim, HK
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 302S - 302S
  • [29] HIGH-DOSE 5-FLUOROURACIL (5-FU) AND FOLINIC ACID IN ADVANCED COLORECTAL SITES OF DISEASE CANCER RESISTANT TO STANDARD-DOSE LOCAL 5-FU TREATMENT - RESULTS OF A LIVER PHASE-II STUDY
    JAGER, E
    KLEIN, O
    WACHTER, B
    MULLER, B
    BRAUN, U
    KNUTH, A
    EUROPEAN JOURNAL OF CANCER, 1995, 31A (10) : 1717 - 1717
  • [30] COMPARISON OF TREATMENT OF METASTATIC GASTROINTESTINAL CANCER WITH 5-FLUOROURACIL (5-FU) TO A COMBINATION OF 5-FU WITH CYTOSINE-ARABINOSIDE
    GAILANI, S
    HOLLAND, JF
    BURNINGHAM, R
    LEONE, L
    LARSEN, V
    FALKSON, G
    CANCER, 1972, 29 (05) : 1308 - +